Dr Daniel Henderson
BSc, BM (with distinction), MRCP (UK), FRCR (Clinical Oncology), MD (Res)
I trained in Clinical Oncology at the Royal Marsden Hospital in London, including a two-year fellowship in Cyberknife radiotherapy (only the second person ever to hold this prestigious fellowship). I have published a number of research papers and spoken at national and international conferences.
I was appointed as a Consultant in Clinical Oncology at Queen Elizabeth Hospital in Edgbaston and Good Hope Hospital in Sutton Coldfield in November 2017, caring for patients with Breast and Prostate cancer. I am a member of the Expert Advisory Group for both Breast Cancer in the West Midlands and also sit on the Scientific Advisory Committee for clinical trials at the Queen Elizabeth Hospital.
Oncology is a fascinating and dynamic speciality with new treatments emerging regularly. My focus is on developing a personalised treatment plan for each patient to achieve the best possible outcomes.
Some of the principal treatments carried out by Dr Daniel Henderson at Spire include:
Chemotherapy and targeted therapy for breast cancer.
Radiotherapy for breast cancer using heart-sparing techniques.
Curative radiotherapy for prostate cancer including IMRT and Cyberknife.
Treatments for advanced prostate cancer.
Spire Little Aston Hospital is only able to provide Covid-19 tests to patients undergoing surgery at our hospital. Covid-19 testing or antibody tests are not available as a standalone service.
BSc, BM (with distinction), MRCP (UK), FRCR (Clinical Oncology), MD (Res) / Queen Elizabeth Hospital / 2017
Clinical Oncology Consulatnt
Member of the Royal College of Physicians
Fellow of the Royal College of Radiologists
UK Breast Cancer Group
British Uro-oncology Group